JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
MBI
MBIA Inc.
There isn't enough reported data to score MBI yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
MBI Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
MBI's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like MBI.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
MBI PE Valuation
MBI has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
MBI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Decline | |
| -- | |
| Limited | |
| Moderate |
Analysts expect MBI's losses to shrink, with revenue declining.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over MBI on earnings quality, reporting a profit while its opponent remains loss making.
MBI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.21 | +$0.43 |
| Q2 2026 | -$2.89 | +$1.76 |
| Q1 2026 | -$3.10 | +$5.78 |
| Q4 2025 | -$3.58 | +$5.86 |
| Q3 2025 | -$3.64 | +$7.44 |
| Q2 2025 | -$4.65 | +$9.19 |
| Q1 2025 | -$8.88 | +$1.07 |
| Q4 2024 | -$9.44 | +$0.53 |
MBI is still losing money, but far less than before: $3.21 per share over the past year, against $13.84 at its worst in mid-2024.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM has the edge over MBI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over MBI on profitability, with a higher operating margin.
MBI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $26M | +73% |
| Q2 2026 | $27M | +17% |
| Q1 2026 | $24M | +71% |
| Q4 2025 | $28M | -24% |
| Q3 2025 | $15M | -48% |
| Q1 2025 | $14M | +7.7% |
| Q3 2024 | $29M | +263% |
| Q1 2024 | $13M | +550% |
MBI's revenue is recovering but still below its 2020 peak: $26M last quarter, up 73% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -88% | -42 points |
| Q2 2026 | -159% | +84 points |
| Q1 2026 | -171% | +272 points |
| Q4 2025 | -200% | -65 points |
| Q3 2025 | -47% | +129 points |
| Q2 2025 | -243% | N/A |
| Q1 2025 | -443% | +226 points |
| Q4 2024 | -135% | N/A |
MBI's operating margin was −88% last quarter, down 42 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
MBI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$73M | -181% |
| Q2 2026 | -$4M | -500% |
| Q1 2026 | -$33M | +$10M |
| Q4 2025 | -$10M | -433% |
| Q3 2025 | $90M | +$229M |
| Q2 2025 | $1M | +$11M |
| Q1 2025 | -$43M | -$13M |
| Q4 2024 | $3M | +$5M |
MBI's free cash flow was −$120M over the past year, against $51M the year before. Free cash flow isn't a meaningful measure for financial services companies like MBI.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over MBI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
MBI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +64.9K shares |
| 1 year | +1.3% | +665K shares |
| 3 years | +6.9% | +3.3M shares |
| 5 years | +1.4% | +710K shares |
| Available history | -38% | -30.8M shares |
MBI has 50M diluted shares, up 1.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $1M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $7M |
| Q4 2024 | — |
MBI spent $1M buying back its own shares over the past year, down 86% from the year before.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
MBI Net Leverage
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
MBI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.6 | Neutral |
| Stochastic | 33.3 | Neutral |
MBI's weekly RSI is 40 (neutral) and its Stochastic is 33 (neutral).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
MBI PE vs Financial Services Sector
MBI has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over MBI on trend strength, trading above more of its moving averages.
MBI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.49 | 4.2% above |
| 20 week MA | $5.01 | 6.6% below |
| 50 week MA | $5.82 | 20% below |
| 100 week MA | $5.88 | 20% below |
| 200 week MA | $6.60 | 29% below |
MBI has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 29% below its 200-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over MBI on returns for 2026, with the stronger performance.
MBI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.26 | $6.95 | -25% |
| 2021 | $6.95 | $12.4 | +79% |
| 2022 | $12.4 | $12.9 | +3.7% |
| 2023 | $12.9 | $6.12 | -53% |
| 2024 | $6.12 | $6.10 | -0.3% |
| 2025 | $6.10 | $7.12 | +17% |
| 2026 YTD | $7.12 | $4.68 | -34% |
MBI has finished lower in three of the last six years. It's down 34% so far in 2026.